Skip to main content
Erschienen in: European Radiology 3/2015

01.03.2015 | Cardiac

Diagnostic performance of computed tomography for detection of concomitant coronary disease in hypertrophic cardiomyopathy

verfasst von: Lei Zhao, Xiaohai Ma, Hailong Ge, Chen Zhang, Zhanhong Wang, Kunihiko Teraoka, Zhanming Fan

Erschienen in: European Radiology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the diagnostic performance of computed tomography (CT) in patients with hypertrophic cardiomyopathy (HCM) and suspected coexistent coronary artery diseases (CADs).

Methods

Sixty patients were enrolled in this study. Cardiac CT examination included CT coronary angiography (CTCA) and delayed enhancement CT. CT performance in evaluation of the coronary artery was assessed and compared with that of catheter-based coronary angiography (CA). The left ventricle (LV) wall thickness, functional indices and myocardial delayed enhancement (MDE) were measured via cardiac magnetic resonance (CMR) and CT images.

Results

Compared with catheter-based CA, CTCA produced a 100 % (24/24) sensitivity, a 94.4 % (34/36) specificity, a 92.3 % (24/26) positive predictive value and a 100 % (34/34) negative predictive value. CT-measured LV wall thickness and functional indices were correlated with those measured via CMR (P < 0.01), though the CT-measured values were smaller than the CMR-measured values. Bland-Altman analysis showed the volume of the focal MDE determined via CT was slightly smaller than that determined using CMR (mean difference: 0.3 cm3).

Conclusions

For patients with HCM and suspected coexistent CAD, this comprehensive cardiac CT protocol can be helpful in ruling out coronary stenosis and can provide information regarding morphology, function and tissue characterization of the LV myocardium.

Key Points

Multislice computed tomography (MSCT) can evaluate coronary arteries in HCM patients with coexisting CAD
Delayed enhancement CT can show the myocardial fibrosis in HCM patients
MSCT may provide information regarding coronary stenosis and myocardial fibrosis
Literatur
1.
Zurück zum Zitat Kubo T, Kitaoka H, Okawa M, Nishinaga M, Doi YL (2010) Hypertrophic cardiomyopathy in the elderly. Geriatr Gerontol Int 10:9–16CrossRefPubMed Kubo T, Kitaoka H, Okawa M, Nishinaga M, Doi YL (2010) Hypertrophic cardiomyopathy in the elderly. Geriatr Gerontol Int 10:9–16CrossRefPubMed
2.
Zurück zum Zitat Maron BJ, Niiura H, Casey SA, Soper MK, Wright GB, Seidman JG et al (2001) Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 38:315–321CrossRefPubMed Maron BJ, Niiura H, Casey SA, Soper MK, Wright GB, Seidman JG et al (2001) Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 38:315–321CrossRefPubMed
3.
Zurück zum Zitat Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Berger PB, Tajik AJ (2003) Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation 108:2342–2348CrossRefPubMed Sorajja P, Ommen SR, Nishimura RA, Gersh BJ, Berger PB, Tajik AJ (2003) Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease. Circulation 108:2342–2348CrossRefPubMed
4.
Zurück zum Zitat Okayama S, Soeda T, Kawakami R, Takami Y, Somekawa S, Ueda T et al (2013) Evaluation of coronary artery disease and cardiac morphology and function in patients with hypertrophic cardiomyopathy, using cardiac computed tomography. Heart Vessels 2013 Dec 11. [Epub ahead of print] Okayama S, Soeda T, Kawakami R, Takami Y, Somekawa S, Ueda T et al (2013) Evaluation of coronary artery disease and cardiac morphology and function in patients with hypertrophic cardiomyopathy, using cardiac computed tomography. Heart Vessels 2013 Dec 11. [Epub ahead of print]
5.
Zurück zum Zitat Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American college of cardiology foundation/american heart association task force on practice guidelines. Developed in collaboration with the American association for thoracic surgery, American society of echocardiography, American society of nuclear cardiology, heart failure society of America, heart rhythm society, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol 58:e212–e260CrossRefPubMed Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS et al (2011) 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American college of cardiology foundation/american heart association task force on practice guidelines. Developed in collaboration with the American association for thoracic surgery, American society of echocardiography, American society of nuclear cardiology, heart failure society of America, heart rhythm society, society for cardiovascular angiography and interventions, and society of thoracic surgeons. J Am Coll Cardiol 58:e212–e260CrossRefPubMed
6.
Zurück zum Zitat Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademarkers FE et al (2004) Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 25:1940–1965CrossRefPubMed Pennell DJ, Sechtem UP, Higgins CB, Manning WJ, Pohost GM, Rademarkers FE et al (2004) Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 25:1940–1965CrossRefPubMed
7.
Zurück zum Zitat Lima JA, Desai MY (2004) Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 44:1164–1171CrossRefPubMed Lima JA, Desai MY (2004) Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 44:1164–1171CrossRefPubMed
8.
Zurück zum Zitat Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I et al (2009) Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 54:220–228CrossRefPubMed Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I et al (2009) Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 54:220–228CrossRefPubMed
9.
Zurück zum Zitat Mahnken AH, Koos R, Katoh M, Widberger JE, Spuentrup E, Buecker A et al (2005) Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol 45:2042–2047CrossRefPubMed Mahnken AH, Koos R, Katoh M, Widberger JE, Spuentrup E, Buecker A et al (2005) Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol 45:2042–2047CrossRefPubMed
10.
Zurück zum Zitat Baks T, Cademartiri MAD, van der Giessen WJ, Krestin GP, Duncker DJ et al (2007) Assessment of acute reperfused myocardial infarction with delayed enhancement 64-MDCT. AJR 188:w135–w137CrossRefPubMed Baks T, Cademartiri MAD, van der Giessen WJ, Krestin GP, Duncker DJ et al (2007) Assessment of acute reperfused myocardial infarction with delayed enhancement 64-MDCT. AJR 188:w135–w137CrossRefPubMed
11.
Zurück zum Zitat Lardo AC, Cordeiro MA, Silva C, Amado LC, George RT, Saliaris AP et al (2006) Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation 113:394–404CrossRefPubMedCentralPubMed Lardo AC, Cordeiro MA, Silva C, Amado LC, George RT, Saliaris AP et al (2006) Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation 113:394–404CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Polain L, de Waroux JB, Pouleur AC, Goffinet C, Pasquet A, Vanoverschelde JL, Gerber BL (2008) Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging. Eur Heart J 29:2544–2551CrossRef Polain L, de Waroux JB, Pouleur AC, Goffinet C, Pasquet A, Vanoverschelde JL, Gerber BL (2008) Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging. Eur Heart J 29:2544–2551CrossRef
13.
Zurück zum Zitat Nieman K, Shapiro MD, Ferencik M, Nomura CH, Abbara S, Hoffmann U et al (2008) Reperfused myocardial infarction: contrast-enhanced 64-section CT in comparison to MR imaging. Radiology 247:49–56CrossRefPubMed Nieman K, Shapiro MD, Ferencik M, Nomura CH, Abbara S, Hoffmann U et al (2008) Reperfused myocardial infarction: contrast-enhanced 64-section CT in comparison to MR imaging. Radiology 247:49–56CrossRefPubMed
14.
Zurück zum Zitat Meijboom WB, van Mieghem CA, Mollet NR, Pugliese F, Weustink AC, van Pelt N et al (2007) 64-slice computed tomography coronary angiography in patients with high, intermediate, or low pretest probability of significant coronary artery disease. J Am Coll Cardiol 50:1469–1475CrossRefPubMed Meijboom WB, van Mieghem CA, Mollet NR, Pugliese F, Weustink AC, van Pelt N et al (2007) 64-slice computed tomography coronary angiography in patients with high, intermediate, or low pretest probability of significant coronary artery disease. J Am Coll Cardiol 50:1469–1475CrossRefPubMed
15.
Zurück zum Zitat Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF et al (2002) ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American college of cardiology/ American heart association task force on practice guidelines (committee to update the 1997 exercise testing guidelines). J Am Coll Cardiol 40:1531–1540CrossRefPubMed Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF et al (2002) ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American college of cardiology/ American heart association task force on practice guidelines (committee to update the 1997 exercise testing guidelines). J Am Coll Cardiol 40:1531–1540CrossRefPubMed
16.
Zurück zum Zitat Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmr GJ, Eagle KA et al (1999) ACC/AHA guidelines for coronary angiography. A report of the American college of cardiology/American heart association task force on practice guidelines (committee on coronary angiography). Developed in collaboration with the society for cardiac angiography and interventions. J Am Coll Cardiol 33:1756–1824CrossRefPubMed Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmr GJ, Eagle KA et al (1999) ACC/AHA guidelines for coronary angiography. A report of the American college of cardiology/American heart association task force on practice guidelines (committee on coronary angiography). Developed in collaboration with the society for cardiac angiography and interventions. J Am Coll Cardiol 33:1756–1824CrossRefPubMed
17.
Zurück zum Zitat Leber AW, Knez A, von Ziegler F, Becker A, Nikolaou K, Paul S et al (2005) Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 46:147–152CrossRefPubMed Leber AW, Knez A, von Ziegler F, Becker A, Nikolaou K, Paul S et al (2005) Quantification of obstructive and nonobstructive coronary lesions by 64-slice computed tomography: a comparative study with quantitative coronary angiography and intravascular ultrasound. J Am Coll Cardiol 46:147–152CrossRefPubMed
18.
Zurück zum Zitat Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542CrossRefPubMed
19.
Zurück zum Zitat Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1561–1567CrossRefPubMed Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1561–1567CrossRefPubMed
20.
Zurück zum Zitat Christner JA, Kofler JM, McCollough CH (2010) Estimating effective dose for CT using dose-length product compared with using organ doses: consequences of adopting international commission on radiological protection publication 103 or dual-energy scanning. AJR Am J Roentgenol 194:881–889CrossRefPubMed Christner JA, Kofler JM, McCollough CH (2010) Estimating effective dose for CT using dose-length product compared with using organ doses: consequences of adopting international commission on radiological protection publication 103 or dual-energy scanning. AJR Am J Roentgenol 194:881–889CrossRefPubMed
21.
Zurück zum Zitat Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE et al (2009) The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 54:866–875CrossRefPubMed Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE et al (2009) The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 54:866–875CrossRefPubMed
22.
Zurück zum Zitat Zhao L, Ma X, DeLano MC, Jiang T, Zhang C, Liu Y et al (2013) Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography. Eur Radiol 23:1034–1043CrossRefPubMed Zhao L, Ma X, DeLano MC, Jiang T, Zhang C, Liu Y et al (2013) Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography. Eur Radiol 23:1034–1043CrossRefPubMed
23.
Zurück zum Zitat Ordovas KG, Higgins CB (2011) Delayed contrast enhancement on MR images of myocardium: past, present, future. Radiology 261:358–374CrossRefPubMed Ordovas KG, Higgins CB (2011) Delayed contrast enhancement on MR images of myocardium: past, present, future. Radiology 261:358–374CrossRefPubMed
24.
Zurück zum Zitat Chun EJ, Choi SI, Jin KN, Kwag HJ, Kim YJ, Choi BW et al (2010) Hypertrophic cardiomyopathy: assessment with MR imaging and multidetector CT. Radiographics 30:1309–1328CrossRefPubMed Chun EJ, Choi SI, Jin KN, Kwag HJ, Kim YJ, Choi BW et al (2010) Hypertrophic cardiomyopathy: assessment with MR imaging and multidetector CT. Radiographics 30:1309–1328CrossRefPubMed
25.
Zurück zum Zitat Berliner JI, Kino A, Carr JC, Bonow RO, Choudhury L (2013) Cardiac computed tomographic imaging to evaluate myocardial scarring/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging. Int J Cardiovasc Imaging 29:191–197CrossRefPubMed Berliner JI, Kino A, Carr JC, Bonow RO, Choudhury L (2013) Cardiac computed tomographic imaging to evaluate myocardial scarring/fibrosis in patients with hypertrophic cardiomyopathy: a comparison with cardiac magnetic resonance imaging. Int J Cardiovasc Imaging 29:191–197CrossRefPubMed
26.
Zurück zum Zitat Chan RH, Maron B, Olivotto I, Assenza G, Hong MS, Lesser J et al (2012) Prognostic utility of contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: an international multicenter study. J Am Coll Cardiol 59(13s1):E1570CrossRef Chan RH, Maron B, Olivotto I, Assenza G, Hong MS, Lesser J et al (2012) Prognostic utility of contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: an international multicenter study. J Am Coll Cardiol 59(13s1):E1570CrossRef
27.
Zurück zum Zitat Naehle CP, Kreuz J, Strach K, Schwab JO, Pingel S, Luechinger R et al (2011) Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pace makers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J 16:1096–1105CrossRef Naehle CP, Kreuz J, Strach K, Schwab JO, Pingel S, Luechinger R et al (2011) Safety, feasibility, and diagnostic value of cardiac magnetic resonance imaging in patients with cardiac pace makers and implantable cardioverters/defibrillators at 1.5 T. Am Heart J 16:1096–1105CrossRef
Metadaten
Titel
Diagnostic performance of computed tomography for detection of concomitant coronary disease in hypertrophic cardiomyopathy
verfasst von
Lei Zhao
Xiaohai Ma
Hailong Ge
Chen Zhang
Zhanhong Wang
Kunihiko Teraoka
Zhanming Fan
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 3/2015
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3465-6

Weitere Artikel der Ausgabe 3/2015

European Radiology 3/2015 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.